HOXA9 Antikörper (AA 63-272)
-
- Target Alle HOXA9 Antikörper anzeigen
- HOXA9 (Homeobox A9 (HOXA9))
-
Bindungsspezifität
- AA 63-272
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HOXA9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Protein A Chromatography
- Immunogen
- A partial length recombinant HOXA9 protein (amino acids 63-272) was used as the immunogen for this antibody.
- Isotyp
- IgG
- Top Product
- Discover our top product HOXA9 Primärantikörper
-
anti-Homeobox A9 (HOXA9) (AA 1-272) antibody
HOXA9 Reaktivität: Human WB, ELISA, IHC, FACS, ICC Wirt: Maus Monoclonal 1A12C1 unconjugated
anti-Homeobox A9 (HOXA9) (AA 1-272) antibodyHOXA9 Reaktivität: Human WB, ELISA, IHC, FACS, ICC Wirt: Maus Monoclonal 5C7C6 unconjugated
anti-Homeobox A9 (HOXA9) (AA 1-272) antibodyHOXA9 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 2A11-2D2 unconjugated
anti-Homeobox A9 (HOXA9) (AA 1-190) antibodyHOXA9 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Homeobox A9 (HOXA9) (Internal Region) antibodyHOXA9 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Homeobox A9 (HOXA9) (AA 245-272) antibodyHOXA9 Reaktivität: Human WB, ELISA, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Homeobox A9 (HOXA9) (AA 245-272), (C-Term) antibodyHOXA9 Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB17856 unconjugated
anti-Homeobox A9 (HOXA9) (AA 1-190) antibodyHOXA9 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Homeobox A9 (HOXA9) antibodyHOXA9 Reaktivität: Human WB, IHC Wirt: Kaninchen Monoclonal unconjugated
anti-Homeobox A9 (HOXA9) (AA 160-189) antibodyHOXA9 Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB38445 unconjugated
-
- Applikationshinweise
- WB: 1-2 μg/mL
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.5 mg/mL
- Buffer
- PBS containing 0.05 % BSA, PH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.
-
- Target
- HOXA9 (Homeobox A9 (HOXA9))
- Andere Bezeichnung
- HOXA9 (HOXA9 Produkte)
- Synonyme
- HOXA9 antikoerper, XlHbox-6 antikoerper, XlHbox6 antikoerper, hoxa9-A antikoerper, xhoxa9 antikoerper, HOXA-9 antikoerper, ABD-B antikoerper, HOX1 antikoerper, HOX1.7 antikoerper, HOX1G antikoerper, D6a9 antikoerper, Hox-1.7 antikoerper, Hox1r5 antikoerper, Hoxa7 antikoerper, homeobox A9 antikoerper, homeobox protein Hox-A9 antikoerper, homeobox A9 S homeolog antikoerper, homeobox A7 antikoerper, HOXA9 antikoerper, LOC745701 antikoerper, hoxa9 antikoerper, hoxa9.S antikoerper, Hoxa9 antikoerper, Hoxa7 antikoerper
- Hintergrund
- HOXA9 is a well-studied member of the HOXA cluster, and it plays a significant role in both normal hematopoiesis and leukemogenesis. HOXA9 is expressed in EC (Endothelial Cells) and its expression is rapidly downregulated during EC activation by inflammatory signals like TNF-alpha (Tumor Necrosis Factor-Alpha) and LPS (lipopolysaccharide) . In humans,HOXA9 was found to be highly expressed and required in some subtypes of leukemia, particularly mixed lineage leukemia (MLL)-rearranged leukemia. The aberrant overexpression of HOXA9 is thought to be associated with poor survival of acute myeloid leukemia (AML) patients.
- Molekulargewicht
- 30 kDa
- Gen-ID
- 3205
- UniProt
- P31269
-
